External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home 2026 ASCO® Genitourinary Cancers Symposium
Roche and Genentech at

2026 ASCO® Genitourinary Cancers Symposium

February 26 - February 28
San Francisco, USA / Virtual (Hybrid)
conferences.asco.org
We will be contributing to topics related to
Oncology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
04:25 PM
Duration 10mins San Francisco
Circulating tumor (ct)DNA-guided adjuvant atezolizumab (atezo) in muscle-invasive bladder cancer (MIBC): Exploratory analysis of ctDNA dynamics in the IMvigor011 trial
Thomas Powles, Jessica Grindheim, Mesut Yılmaz, Grigorios Rallis, Mahmut Gümüş, Consuelo Buttigliero, Teresa Bonfill, Franco Nolè, Ho Kyung Seo, Michaela Matoušková, Iwona Skoneczna, Wim Demey, Patrizia Giannatempo, Sylvie Rottey, Damien Pouessel, Syed A. Hussain, Elizabeth E. Steinberg, Richard Price, Yohann Loriot, Joaquim Bellmunt
Oncology | Muscle Invasive Urothelial Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.